+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Takeda Pharmaceutical Company Limited - logo

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

Rituximab Biosimilars Market Report and Forecast 2023-2031 - Product Thumbnail Image

Rituximab Biosimilars Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
MTORC1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

MTORC1 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fabry Disease Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031 - Product Thumbnail Image

Fabry Disease Therapeutic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

  • Report
  • June 2023
  • 115 Pages
  • Global
From
Next-Generation Antibody Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Next-Generation Antibody Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
North America Intravenous Immunoglobulin Market Size and Forecasts 2020-2030, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, Distribution Channel, End User, and Country - Product Thumbnail Image

North America Intravenous Immunoglobulin Market Size and Forecasts 2020-2030, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, Distribution Channel, End User, and Country

  • Report
  • October 2023
  • 107 Pages
  • North America
From
Anti-CD38 antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD38 antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact and Forecasts (2023-2028) - Product Thumbnail Image

Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact and Forecasts (2023-2028)

  • Report
  • April 2023
  • 107 Pages
  • Global
From
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 700 Pages
  • Global
From
Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World - Product Thumbnail Image

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

  • Report
  • November 2023
  • 63 Pages
  • Global
Eosinophilic Esophagitis (EoE): Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Eosinophilic Esophagitis (EoE): Opportunity Assessment and Forecast - Update

  • Report
  • August 2025
  • 66 Pages
  • Global
From
Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Lennox-Gastaut Syndrome - Global Clinical Trials Review, 2025

  • Clinical Trials
  • July 2025
  • 195 Pages
  • Global
From
Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 - Product Thumbnail Image

Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

  • Drug Pipelines
  • May 2023
  • 151 Pages
  • Global
From
Alzheimer's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Alzheimer's Disease Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 189 Pages
  • Global
From
Proteasome Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Proteasome Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aurora-A Kinase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Aurora-A Kinase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

  • Report
  • April 2025
  • 90 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
BRAFV600 Mutation (B-Raf Proto-oncogene, Serine/threonine Kinase) Inhibiotors - Pipeline Insight, 2025 - Product Thumbnail Image

BRAFV600 Mutation (B-Raf Proto-oncogene, Serine/threonine Kinase) Inhibiotors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
CCR2 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

CCR2 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Vestibular Schwannoma - Pipeline Insight, 2025 - Product Thumbnail Image

Vestibular Schwannoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Loading Indicator